William A Hawkins
CIK 1106508 · Chairman & CEO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BVS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
710 MEDTRONIC PKWY, MS LC310
MINNEAPOLIS, MN 55432-5604
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDXG | Director | 254,931 | $4.38 | $1.12M | $0 | 9 | 2026-06-12 |
| BIIB | Director | 10,365 | $233.48 | $2.42M | $0 | 8 | 2026-06-11 |
| BVS | Director | 297,640 | $13.49 | $4.02M | $235.6K | 13 | 2026-06-04 |
| AVANOS MEDICAL, INC. (AVNS) Delisted | Director | 31,197 | $24.99 | $779.6K | $0 | 3 | 2021-01-06 |
| AVANOS MEDICAL, INC. (HYH) Delisted | Director | 17,651 | — | — | $0 | 5 | 2018-05-04 |
| THOR | Director | 0 | $25.23 | $0 | $0 | 5 | 2015-10-08 |
| MDT | Chairman & CEO | 434,032 | $92.77 | $40.27M | $149.8K | 15 | 2011-06-06 |
| DLX | Director | 11,333 | $22.81 | $258.5K | $0 | 3 | 2007-06-19 |
Recent Filings · Page 3 of 7
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-14 | BVS | Exer (M) | +38,288 | $0 | EDGAR |
| 2021-07-02 | BIIB | Grant (A) | +775 | $0 | EDGAR |
| 2021-05-28 | MDXG | Grant (A) | +17,056 | $175.0K | EDGAR |
| 2021-04-05 | BVS | Grant (A) | — | $0 | EDGAR |
| 2021-02-16 | BVS | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | AVANOS MEDICAL, INC. (AVNS) Delisted | Grant (A) | +4,005 | $0 | EDGAR |
| 2020-12-18 | MDXG | Grant (A) | +15,964 | $125.0K | EDGAR |
| 2020-10-05 | MDXG | Grant (A) | +26,236 | $175.0K | EDGAR |
| 2020-08-28 | MDXG | Grant (A) | +13,418 | $79.2K | EDGAR |
| 2020-06-05 | BIIB | Grant (A) | +890 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.